1. Abulaban KM, Fall N, Nunna R, Ying J, Devarajan P, Grom A, Bennett M, Ardoin SP, Brunner HI. Relationship of Cell-Free Urine MicroRNA with Lupus Nephritis in Children. Pediatr Rheumatol Online J. 2016; 14:4.
  2. Aggarwal R, Ringold S, Khanna D, Neogi T, Johnson S, Miller A, Brunner H, Ogawa R, Felson D, Ogdie A. Distinctions between Diagnostic and Classification Criteria? Arthritis Care Res (Hoboken). 2015; 67:891-97.
  3. Askew RL, Cook KF, Keefe FJ, Nowinski CJ, Cella D, Revicki DA, Morgan DeWitt EM, Michaud K, Trence DL, Amtmann D. A Promis Measure of Neuropathic Pain Quality. Value Health. 2016; 19:623-30.
  4. Bracaglia C, de G, K, Marafon D, Guilhot F, Ferlin W, Prencipe G, Caiello I, Davì S, Schulert G, Ravelli A. Elevated Circulating Levels of Interferon-? And Interferon-?-Induced Chemokines Characterise Patients with Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis. Ann Rheum Dis. 2016.
  5. Cunningham NR, Tran ST, Lynch-Jordan AM, Ting TV, Sil S, Strotman D, Noll JG, Powers SW, Arnold LM, Kashikar-Zuck S. Psychiatric Disorders in Young Adults Diagnosed with Juvenile Fibromyalgia in Adolescence. J Rheumatol. 2015; 42:2427-33.
  6. DeWalt D, Gross H, Gipson D, Selewski D, DeWitt E, Dampier C, Hinds P, Huang I-C, Thissen D, Varni J. Promis (R) Pediatric Self-Report Scales Distinguish Subgroups of Children within and across Six Common Pediatric Chronic Health Conditions. Qual Life Res. 2015; 24:2195-208.
  7. Dodds CM, Britto MT, Denson LA, Lovell DJ, Saeed S, Lipstein EA. Physicians' Perceptions of Shared Decision Making in Chronic Disease and Its Barriers and Facilitators. J Pediatr. 2016; 171:307-9 e1-2.
  8. Feldon M, Sikora K, Huggins JL, Billings SD, McMasters R, Brunner HI. Polyarticular Arthritis and Skin Nodulosis in a 14-Year-Old Female. Arthritis Care Res (Hoboken). 2016; 68:700-5.
  9. Grom A. Juvenile Idiopathic Arthritis: Epidemiology and Immunopathogenesis. Watham MA: UpToDate; 2015 [updated August 24, 2015].
  10. Grom AA, Horne A, De Benedetti F. Macrophage Activation Syndrome in the Era of Biologic Therapy. Nat Rev Rheumatol. 2016; 12:259-68.
  11. Grom AA, Ilowite NT, Pascual V, Brunner HI, Martini A, Lovell D, Ruperto N, Paediatric Rheumatology International Trials O, the Pediatric Rheumatology Collaborative Study G, Leon K, Lheritier K, Abrams K. Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Canakinumab. Arthritis Rheumatol. 2016; 68:218-28.
  12. Gulati G, Jones J, Lee G, Altaye M, Beebe D, Meyers-Eaton J, Wiley K, Brunner H, DiFrancesco M. Blood Brain Barrier Permeability Is Altered in Patients with Systemic Lupus Erythematosus: A Novel Imaging Approach. Arthritis Care Res (Hoboken). 2016.
  13. Harris JG, Bingham CA, Morgan EM. Improving Care Delivery and Outcomes in Pediatric Rheumatic Diseases. Curr Opin Rheumatol. 2016; 28:110-6.
  14. Jacobson CJ, Jr., Kashikar-Zuck S, Farrell J, Barnett K, Goldschneider K, Dampier C, Cunningham N, Crosby L, DeWitt EM. Qualitative Evaluation of Pediatric Pain Behavior, Quality, and Intensity Item Candidates and the Promis Pain Domain Framework in Children with Chronic Pain. J Pain. 2015; 16:1243-55.
  15. Jones J, Carle A, Wootton J, Liberio B, Lee J, Schanberg L, Ying J, DeWitt E, Brunner H. Validation of Patient-Reported Outcomes Measurement Information System (Promis®) Short Forms for Use in Childhood-Onset Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2016.
  16. Jones J, DiFrancesco M, Zaal A, Klein-Gitelman M, Gitelman D, Ying J, Brunner H. Childhood-Onset Lupus with Clinical Neurocognitive Dysfunction Shows Lower Streamline Density and Pairwise Connectivity on Diffusion Tensor Imaging. Lupus. 2015; 24:1081-86.
  17. Jones JT, Cunningham N, Kashikar-Zuck S, Brunner HI. Pain, Fatigue, and Psychological Impact on Health-Related Quality of Life in Childhood-Onset Lupus. Arthritis Care Res (Hoboken). 2016; 68:73-80.
  18. Kashikar-Zuck S, Carle A, Barnett K, Goldschneider KR, Sherry DD, Mara CA, Cunningham N, Farrell J, Tress J, DeWitt EM. Longitudinal Evaluation of Patient-Reported Outcomes Measurement Information Systems Measures in Pediatric Chronic Pain. Pain. 2016; 157:339-47.
  19. Kashikar-Zuck S, King C, Ting TV, Arnold LM. Juvenile Fibromyalgia: Different from the Adult Chronic Pain Syndrome? Curr Rheumatol Rep. 2016; 18:19.
  20. Kashikar-Zuck S, Tran ST, Barnett K, Bromberg MH, Strotman D, Sil S, Thomas SM, Joffe N, Ting TV, Williams SE, Myer GD. A Qualitative Examination of a New Combined Cognitive-Behavioral and Neuromuscular Training Intervention for Juvenile Fibromyalgia. Clin J Pain. 2016; 32:70-81.
  21. Lipstein E, Dodds C, Lovell D, Denson L, Britto M. Making Decisions About Chronic Disease Treatment: A Comparison of Parents and Their Adolescent Children. Health Expect. 2016; 19:716-26.
  22. Lovell DJ, Ruperto N, Mouy R, Paz E, Rubio-Perez N, Silva CA, Abud-Mendoza C, Burgos-Vargas R, Gerloni V, Melo-Gomes JA, Saad-Magalhaes C, Chavez-Corrales J, Huemer C, Kivitz A, Blanco FJ, Foeldvari I, Hofer M, Huppertz HI, Job Deslandre C, Minden K, et al. Long-Term Safety, Efficacy, and Quality of Life in Patients with Juvenile Idiopathic Arthritis Treated with Intravenous Abatacept for up to Seven Years. Arthritis Rheumatol. 2015; 67:2759-70.
  23. Lynch-Jordan AM, Sil S, Bromberg M, Ting TV, Kashikar-Zuck S. Cross-Sectional Study of Young Adults Diagnosed with Juvenile Fibromyalgia: Social Support and Its Impact on Functioning and Mood. J Adolesc Health. 2015; 57:482-7.
  24. Mina R, Abulaban K, Klein-Gitelman MS, Eberhard BA, Ardoin SP, Singer N, Onel K, Tucker L, O'Neil K, Wright T, Brooks E, Rouster-Stevens K, Jung L, Imundo L, Rovin B, Witte D, Ying J, Brunner HI. Validation of the Lupus Nephritis Clinical Indices in Childhood-Onset Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2016; 68:195-202.
  25. Mina R, Harris JG, Klein-Gitelman MS, Appenzeller S, Centeville M, Eskra D, Huggins JL, Johnson AL, Khubchandani R, Khandekar P, Lee J, Liu HM, Pendl JD, Silva CA, Silva MF, Zaal AI, DeWitt EM, Ardoin SP, Brunner HI. Initial Benchmarking of the Quality of Medical Care in Childhood-Onset Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2016; 68:179-86.
  26. Moorthy LN, Muscal E, Riebschleger M, Klein-Gitelman M, Nigrovic LE, Horon JR, Rouster-Stevens K, Ferguson PJ, Eberhard BA, Brunner HI, Prahalad S, Schneider R, Nigrovic PA, American College of Rheumatology Special Committee on P, the Investigators of the Childhood A, Rheumatology Research Alliance. Efficacy of an Interinstitutional Mentoring Program within Pediatric Rheumatology. Arthritis Care Res (Hoboken). 2016; 68:645-51.
  27. Ombrello MJ, Remmers EF, Tachmazidou I, Grom A, Foell D, Haas JP, Martini A, Gattorno M, Ozen S, Prahalad S, Zeft AS, Bohnsack JF, et al. Hla-Drb1*11 and Variants of the Mhc Class Ii Locus Are Strong Risk Factors for Systemic Juvenile Idiopathic Arthritis. Proc Natl Acad Sci U S A. 2015; 112:15970-5.
  28. Prasad JM, Gorkun OV, Raghu H, Thornton S, Mullins ES, Palumbo JS, Ko YP, Hook M, David T, Coughlin SR, Degen JL, Flick MJ. Mice Expressing a Mutant Form of Fibrinogen That Cannot Support Fibrin Formation Exhibit Compromised Antimicrobial Host Defense. Blood. 2015; 126:2047-58.
  29. Ravelli A, Minoia F, Davi S, Horne A, Bovis F, Pistorio A, Arico M, Avcin T, Behrens E, De B, F. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis a European League against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Arthritis Rheumatol. 2016; 68:566-76.
  30. Ravelli A, Minoia F, Davi S, Horne A, Bovis F, Pistorio A, Arico M, Avcin T, Behrens E, De B, F. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis a European League against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Ann Rheum Dis. 2016; 75:481-89.
  31. Ravelli A, Minoia F, Davi S, Horne A, Bovis F, Pistorio A, Arico M, Avcin T, Behrens EM, De Benedetti F, Filipovic A, Grom AA, Henter JI, Ilowite NT, Jordan MB, Khubchandani R, Kitoh T, Lehmberg K, Lovell DJ, Miettunen P, et al. Expert Consensus on Dynamics of Laboratory Tests for Diagnosis of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis. RMD Open. 2016; 2:e000161.
  32. Rossetti M, Spreafico R, Consolaro A, Leong JY, Chua C, Massa M, Saidin S, Magni-Manzoni S, Arkachaisri T, Wallace CA, Gattorno M, Martini A, Lovell DJ, Albani S. Tcr Repertoire Sequencing Identifies Synovial Treg Cell Clonotypes in the Bloodstream During Active Inflammation in Human Arthritis. Ann Rheum Dis. 2016.
  33. Scheuern A, Fischer N, McDonald J, Brunner H, Haas J-P, Huegle B. Mutations in the Mthfr Gene Are Not Associated with Methotrexate Intolerance in Patients with Juvenile Idiopathic Arthritis. Pediatr Rheumatol Online J. 2016; 14.
  34. Schmeling H, Mahler M, Levy DM, Moore K, Stevens AM, Wick J, McMillan JD, Horneff G, Assassi S, Charles J, Salazar G, Mayes MD, Silverman ED, Klien-Gitelman M, Lee T, Brunner HI, Reed AM, Fritzler MJ. Autoantibodies to Dense Fine Speckles in Pediatric Diseases and Controls. J Rheumatol. 2015; 42:2419-26.
  35. Schulert G, Fall N, Harley J, Shen N, Lovell D, Thornton S, Grom A. Monocyte MicroRNA Expression in Active Systemic Juvenile Idiopathic Arthritis Implicates Mir-125a-5p in Polarized Monocyte Phenotypes. Arthritis Rheumatol. 2016.
  36. Schulert GS, Bove K, McMasters R, Campbell K, Leslie N, Grom AA. 11-Month-Old Infant with Periodic Fevers, Recurrent Liver Dysfunction, and Perforin Gene Polymorphism. Arthritis Care Res (Hoboken). 2015; 67:1173-9.
  37. Schulert GS, Grom AA. Outburst of Macrophage Activation Syndrome in Mevalonate Kinase Deficiency: Comment on the Article by Schulert Et Al Reply. Arthritis Care Res (Hoboken). 2015; 67:1615-16.
  38. Schulert GS, Zhang M, Fall N, Husami A, Kissell D, Hanosh A, Zhang K, Davis K, Jentzen JM, Napolitano L, Siddiqui J, Smith LB, Harms PW, Grom AA, Cron RQ. Whole-Exome Sequencing Reveals Mutations in Genes Linked to Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome in Fatal Cases of H1n1 Influenza. J Infect Dis. 2016; 213:1180-8.
  39. Spreafico R, Rossetti M, van Loosdregt J, Wallace CA, Massa M, Magni-Manzoni S, Gattorno M, Martini A, Lovell DJ, Albani S. A Circulating Reservoir of Pathogenic-Like Cd4+ T Cells Shares a Genetic and Phenotypic Signature with the Inflamed Synovial Micro-Environment. Ann Rheum Dis. 2016; 75:459-65.
  40. Thornton S, Strait R. Head-to-Head Comparison of Protocol Modifications for the Generation of Collagen-Induced Arthritis in a Specific-Pathogen Free Facility Using Dba/1 Mice. Biotechniques. 2016; 60:119-28.
  41. Ting T, Barnett K, Lynch-Jordan A, Whitacre C, Henrickson M, Kashikar-Zuck S. 2010 American College of Rheumatology Adult Fibromyalgia Criteria for Use in an Adolescent Female Population with Juvenile Fibromyalgia. J Pediatr. 2016; 169:181.
  42. Tran ST, Guite JW, Pantaleao A, Pfeiffer M, Myer GD, Sil S, Thomas SM, Ting TV, Williams SE, Edelheit B, Ounpuu S, Rodriguez-MacClintic J, Zemel L, Zempsky W, Kashikar-Zuck S. Preliminary Outcomes of a Cross-Site Cognitive-Behavioral and Neuromuscular Integrative Training Intervention for Juvenile Fibromyalgia. Arthritis Care Res (Hoboken). 2016.
  43. Turnier JL, Brunner HI. Tocilizumab for Treating Juvenile Idiopathic Arthritis. Expert Opin Biol Ther. 2016; 16:559-66.
  44. Varni JW, Thissen D, Stucky BD, Liu Y, Magnus B, He J, DeWitt EM, Irwin DE, Lai JS, Amtmann D, DeWalt DA. Item-Level Informant Discrepancies between Children and Their Parents on the Promisa (R) Pediatric Scales. Qual Life Res. 2015; 24:1921-37.
  45. Vega-Fernandez P, Vanderburgh White S, Zelko F, Ruth NM, Levy DM, Muscal E, Klein-Gitelman MS, Huber AM, Tucker LB, Roebuck-Spencer T, Ying J, Brunner HI. Cognitive Performance Scores for the Pediatric Automated Neuropsychological Assessment Metrics in Childhood-Onset Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2015; 67:1119-27.
  46. Wherrett DK, Chiang JL, Delamater AM, DiMeglio LA, Gitelman SE, Gottlieb PA, Herold KC, Lovell DJ, Orchard TJ, Ryan CM, Schatz DA, Wendler DS, Greenbaum CJ, Type 1 Diabetes TrialNet Study Group. Defining Pathways for Development of Disease-Modifying Therapies in Children with Type 1 Diabetes: A Consensus Report. Diabetes Care. 2015; 38:1975-85.
  47. Yang X, Sherwin CM, Yu T, Yellepeddi VK, Brunner HI, Vinks AA. Pharmacokinetic Modeling of Therapies for Systemic Lupus Erythematosus. Expert Rev Clin Pharmacol. 2015; 8:587-603.
  48. Zhang M, Bracaglia C, Prencipe G, Bemrich-Stolz CJ, Beukelman T, Dimmitt RA, Chatham WW, Zhang K, Li H, Walter MR, De Benedetti F, Grom AA, Cron RQ. A Heterozygous Rab27a Mutation Associated with Delayed Cytolytic Granule Polarization and Hemophagocytic Lymphohistiocytosis. J Immunol. 2016; 196:2492-503.